Trial Profile

Implementation of pharmacokinetic-guided dosing of DDAVP and VWF-containing concentrates in von Willebrand disease

Status: Recruiting

Phase of Trial: Phase IV

Latest Information Update: 14 Sep 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Desmopressin (Primary) ; Desmopressin (Primary) ; Factor VIII/von Willebrand factor (Primary) ; Von Willebrand factor (Primary)
Indications Von Willebrand disease
Focus Pharmacokinetics
Acronyms OPTI-CLOT: To WiN

Most Recent Events

12 Sep 2023 Planned number of patients changed from 120 to 160.
13 Nov 2019 Planned End Date changed to 14 Feb 2024.
13 Nov 2019 Status changed from not stated to recruiting.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com